FDA Grants Accelerated Approval For Sarepta Muscular Dystrophy Drug Eteplirsen

The FDA has approved the first drug to treat Duchenne muscular dystrophy. The agency's decision went against the recommendation of the panel of experts who did not find eteplirsen effective.